PV4-27345-92974
2 vaccinations
5 coded responses
7 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 565 / MN
- Registered
- 2021-11-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-28
Dose 1 — Pfizer-BioNTech
-
2021-11-17
Dose 2 — Pfizer-BioNTech
-
2021-11-24
Registered in v-safe
- 2021-11-26
- 2021-12-01
-
2021-12-17
Survey response — day 28, dose 2MedDRA: Headache — Feeling: GoodFree text: Daily headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — day 35, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Worsening headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — day 42, dose 2MedDRA: Headache — Feeling: FairFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Survey response — 3 months, dose 2MedDRA: COVID-19, Scleritis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid Scleritis of both eyesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-24
-
2022-11-19
Survey response — 12 months, dose 2MedDRA: Brain fog — Feeling: FairFree text: Brain fog, immensely.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-28 | Pfizer-BioNTech | No |
| 2 | 2021-11-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 28, dose 2
Symptoms: Daily headaches
Release 10 — day 35, dose 2
Symptoms: Worsening headaches
Release 10 — day 42, dose 2
Symptoms: Headaches
Release 11 — 3 months, dose 2
Symptoms: Covid Scleritis of both eyes
Release 12 — 12 months, dose 2
Symptoms: Brain fog, immensely.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Scleritis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release